RxDoctor Payments Data

Morgan Jackson, MD

Family Medicine · Guntersville, ALNPI 1801272638

Payments from drug & device makers

$6,037in general payments, 2019–2025

Across 392 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$832
  • GSK$563
  • Amgen$371
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$271
  • Merck$208
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$6,037100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,037 in reported general payments places this provider in the 85th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$194,770
Medicare patients
514
Services billed
17,120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban312$283,383
OzempicSemaglutide183$216,614
MounjaroTirzepatide183$186,283
JardianceEmpagliflozin163$147,799
TrulicityDulaglutide57$67,877
Trelegy ElliptaFluticasone/Umeclidin/Vilanter69$53,813
JanuviaSitagliptin Phosphate54$43,879
XareltoRivaroxaban54$38,752
FarxigaDapagliflozin Propanediol41$36,265
XifaxanRifaximin12$35,389
VraylarCariprazine Hcl19$29,760
RybelsusSemaglutide14$24,937
EntrestoSacubitril/Valsartan29$23,317
Repatha SureclickEvolocumab34$21,582
MyrbetriqMirabegron18$17,167

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$832$288,882325 claims
Lilly USA, LLCMounjaro, Trulicity$204$254,160240 claims
Novo NordiskOzempic, Rybelsus$202$241,551197 claims
Boehringer IngelheimJardiance, Synjardy, Glyxambi, Stiolto Respimat$74$181,753206 claims
GSKTrelegy Ellipta, Breo Ellipta$563$61,99382 claims
AbbVieVraylar, Linzess, Synthroid$1,523$55,571172 claims
MerckJanuvia$208$43,87954 claims
Johnson & JohnsonXarelto$36$38,75254 claims
AstraZenecaFarxiga$100$36,26541 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$271$35,38912 claims
NovartisEntresto$122$23,31729 claims
Astellas Pharma US IncMyrbetriq$14$17,16718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Guntersville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →